Vaxcyte to Host Webcast and Conference Call to Present Topline Results from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older SAN CARLOS, Calif., Sept. 02, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the...

Vaxcyte Appoints John Furey to Board of Directors Vaxcyte appoints John Furey to Board of Directors.

Vaccines Market Size to Reach USD 73.78 Billion in 2028; Increasing government funding for vaccine production and growing emphasis on immunization are major factors expected to drive the market, Says Reports and Data New York, June 02, 2021 (GLOBE NEWSWIRE) -- Market Size – USD 42 Billion in 2020 Market Growth – 7.3% Market Trends – Expanding pharmaceutical industry and drive to vaccinate all The global...

Vaccines Market worth over $70bn by 2025: Global Market Insights, Inc. Selbyville, Delaware, March 07, 2019 (GLOBE NEWSWIRE) -- The vaccines market is estimated to hike from over USD 38 billion in 2018 to over USD 70 billion by 2025, according to a 2019 Global Market...